Cargando…
A comparison of the efficacy of transplantation of bone marrow-derived mesenchymal stem cells and unrestricted somatic stem cells on outcome after acute myocardial infarction
INTRODUCTION: A number of questions remain unanswered in the field of cell therapy for acute myocardial infarction, including what is the optimal cell type, and can therapeutic efficacy be enhanced by conditioning regimens. In this study, we sought to address these questions by directly comparing th...
Autores principales: | Flynn, Aidan, Chen, Xizhe, O'Connell, Enda, O'Brien, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580427/ https://www.ncbi.nlm.nih.gov/pubmed/22974654 http://dx.doi.org/10.1186/scrt127 |
Ejemplares similares
-
Influence of Xenogeneic and Alloplastic Carriers for Bone Augmentation on Human Unrestricted Somatic Stem Cells
por: Schorn, Lara, et al.
Publicado: (2022) -
Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction
por: Wen, Zhuzhi, et al.
Publicado: (2011) -
Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction
por: Leblond, Anne-Laure, et al.
Publicado: (2009) -
Unrestricted somatic stem cells from human umbilical cord blood grow in serum-free medium as spheres
por: Zaibak, Faten, et al.
Publicado: (2009) -
Immunogenicity of allogeneic mesenchymal stem cells
por: Schu, Sabine, et al.
Publicado: (2012)